Accelerating Gastrointestinal Recovery
This study is designed to determine whether an oral perioperative medication (alvimopan--a selective mu antagonist) improves bowel recovery over placebo after surgery for ovarian cancer.
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
DRUG: Alvimopan|DRUG: Placebo
Postoperative Length of Hospital Stay, Length of stay = date/time of hospital dismissal - date/time of end of surgery, Patients will be followed for the duration of their hospital stay, an expected average of 5 days
Postoperative Ileus Incidence, Ileus was defined as MD-diagnosed, return to nothing by mouth (NPO) status, or insertion of nasogastric tube for ileus., Patients will be followed for 30 days postop
This study is designed to determine whether an oral perioperative medication (alvimopan--a selective mu antagonist) improves bowel recovery over placebo after surgery for ovarian cancer.